| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein dimerization activity | 3.82e-03 | 1205 | 6 | 3 | GO:0046983 | |
| GeneOntologyBiologicalProcess | fluid transport | 6.04e-05 | 42 | 6 | 2 | GO:0042044 | |
| GeneOntologyBiologicalProcess | response to virus | 1.66e-04 | 425 | 6 | 3 | GO:0009615 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 2.79e-04 | 90 | 6 | 2 | GO:0098586 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 3.45e-04 | 100 | 6 | 2 | GO:1903510 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 5.04e-04 | 121 | 6 | 2 | GO:0030203 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 6.00e-04 | 132 | 6 | 2 | GO:0006022 | |
| GeneOntologyBiologicalProcess | cell recognition | 1.34e-03 | 198 | 6 | 2 | GO:0008037 | |
| GeneOntologyBiologicalProcess | vacuole organization | 2.11e-03 | 249 | 6 | 2 | GO:0007033 | |
| GeneOntologyBiologicalProcess | cellular response to oxidative stress | 2.94e-03 | 295 | 6 | 2 | GO:0034599 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 3.16e-03 | 306 | 6 | 2 | GO:0048863 | |
| GeneOntologyBiologicalProcess | telencephalon development | 3.71e-03 | 332 | 6 | 2 | GO:0021537 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 3.86e-03 | 1249 | 6 | 3 | GO:0048878 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 4.76e-03 | 377 | 6 | 2 | GO:0062197 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 4.93e-03 | 1361 | 6 | 3 | GO:0009628 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 6.49e-03 | 442 | 6 | 2 | GO:0050878 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 6.21e-03 | 464 | 4 | 2 | M27547 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN | 7.93e-04 | 193 | 6 | 2 | M6169 | |
| Coexpression | GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN | 8.02e-04 | 194 | 6 | 2 | M9249 | |
| Coexpression | GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN | 8.35e-04 | 198 | 6 | 2 | M3552 | |
| Coexpression | GSE4142_NAIVE_VS_GC_BCELL_UP | 8.43e-04 | 199 | 6 | 2 | M6375 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_UP | 8.43e-04 | 199 | 6 | 2 | M5530 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 8.52e-04 | 200 | 6 | 2 | M9391 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_UP | 8.52e-04 | 200 | 6 | 2 | M4851 | |
| Coexpression | GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP | 8.52e-04 | 200 | 6 | 2 | M9060 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 8.52e-04 | 200 | 6 | 2 | M8007 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN | 8.52e-04 | 200 | 6 | 2 | M4496 | |
| Coexpression | GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN | 8.52e-04 | 200 | 6 | 2 | M6430 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 8.52e-04 | 200 | 6 | 2 | M4480 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 126 | 6 | 2 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-04 | 137 | 6 | 2 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 158 | 6 | 2 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 158 | 6 | 2 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 193 | 6 | 2 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-04 | 194 | 6 | 2 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-04 | 195 | 6 | 2 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-04 | 200 | 6 | 2 | 68b0f987c4fb8078675475f4f1e71302f832ef69 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.91e-04 | 200 | 6 | 2 | 1b527bebbca1ef8c52449e40beb9358e37494e04 | |
| Drug | 4-acetylantroquinonol B | 6.07e-06 | 15 | 6 | 2 | ctd:C555021 | |
| Drug | AC1MMF4B | 1.68e-04 | 77 | 6 | 2 | CID003260010 | |
| Drug | NSC3364 | 3.94e-04 | 118 | 6 | 2 | CID000025439 | |
| Drug | ON 01910 | 7.41e-04 | 162 | 6 | 2 | ctd:C507134 | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 9.54e-04 | 184 | 6 | 2 | 4994_UP | |
| Drug | trichostatin A; Up 200; 0.1uM; PC3; HG-U133A | 1.03e-03 | 191 | 6 | 2 | 448_UP | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 4503_UP | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 2775_UP | |
| Drug | W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.06e-03 | 194 | 6 | 2 | 440_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 7000_UP | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 1.07e-03 | 195 | 6 | 2 | 1138_DN | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 5474_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 2283_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2560_UP | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2778_UP | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 7301_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 7335_DN | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 6131_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 2518_UP | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 4659_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5006_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5492_UP | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 2162_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 6508_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 7437_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 2348_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 3238_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 2157_DN | |
| Disease | basophil count | 2.59e-03 | 483 | 5 | 2 | EFO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FFIHYPYCYGYWKKY | 121 | Q86UA1 | |
| FADLKKYHFYYWFCY | 136 | O95352 | |
| KYHFYYWFCYPALCL | 141 | O95352 | |
| YHKYYHYLYSHYLPA | 626 | Q16394 | |
| WGYYLFPDCYNHHYK | 216 | P38567 | |
| KIFWKYYYGHYLDDY | 496 | Q8NBS3 | |
| FWYAPECLKEYKFYY | 1066 | P29597 |